Joan Merrill, M.D., is a recipient of the 2018 ACR Master designation, one of the highest honors members can receive.
OMRF
50 years after terminal diagnosis, Greg Kindell is still here
In 1968, doctors told Greg Kindell that he had acute myeloid leukemia and he had just six weeks to live. Now he’s been cancer-free for 50 years.
OMRF elects four new board members
OMRF named Leigh Ann Albers, Tricia Everest, Ronnie Irani and Dr. Barry Pollard to its board of directors.
OMRF adds three new researchers
The trio of scientists assumed their new positions at the foundation Nov. 1, bringing the total number of OMRF senior scientists to 49.
OMRF welcomes trick-or-treaters from Positive Tomorrows
For the 12th consecutive year, OMRF hosted a Halloween event for more than 70 trick-or-treaters from Positive Tomorrows.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
